Evidence map›Paper›PMID 33704933›Full record

ArticleAnnals of clinical and translational neurology2021

QSM is an imaging biomarker for chronic glial activation in multiple sclerosis lesions.

Kelly M Gillen, Mayyan Mubarak, Calvin Park, Gerald Ponath, Shun Zhang, Alexey Dimov, Maya Levine-Ritterman, Steven Toro, Weiyuan Huang, Stephanie Amici and 6 more

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 84 citations in OpenAlex.

  1. Pooled it
  2. Brain oxygen extraction fraction mapping in patients with multiple sclerosis.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2022
    Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Updates in Multiple Sclerosis Imaging.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2025
    Review
  10. Review
  11. Quantitative imaging in medicine and surgery · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Imaging Outcomes for Phase 2 Trials Targeting Compartmentalized Inflammation.Multiple sclerosis (Houndmills, Basingstoke, England) · 2024
    Review
  19. Observational
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Kelly M GillenDepartment of Radiology, Weill Cornell Medicine, New York, New York, USA.ORCID 0000-0003-1319-4900
Mayyan MubarakDepartment of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.
Calvin ParkDepartment of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.
Gerald PonathDepartment of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.
Shun ZhangDepartment of Radiology, Weill Cornell Medicine, New York, New York, USA.
Alexey DimovDepartment of Radiology, Weill Cornell Medicine, New York, New York, USA.
Maya Levine-RittermanDepartment of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.
Steven ToroDepartment of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.
Weiyuan HuangDepartment of Radiology, Weill Cornell Medicine, New York, New York, USA.
Stephanie AmiciDepartment of Neuroscience, The Ohio State University, Columbus, Ohio, USA.
Ulrike W KaunznerDepartment of Neurology, Weill Cornell Medicine, New York, New York, USA.
Susan A GauthierDepartment of Radiology, Weill Cornell Medicine, New York, New York, USA.ORCID 0000-0002-4015-1781
Mireia Guerau-de-ArellanoDepartment of Neuroscience, The Ohio State University, Columbus, Ohio, USA.
Yi WangDepartment of Radiology, Weill Cornell Medicine, New York, New York, USA.
Thanh D NguyenDepartment of Radiology, Weill Cornell Medicine, New York, New York, USA.
David PittDepartment of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0002-6407-9542
Cornell University · USYale University · USThe Ohio State University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
No-Gd MRI for Monitoring Disease Status in Multiple SclerosisR01NS105144 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI GAUTHIER, SUSAN A, GUPTA, AJAY · 2018 to 2022
$2.8M
Multiple Sclerosis Lesion Magnetic Susceptibility ActivityR01NS090464 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI WANG, YI · 2015 to 2020
$2.3M
Epigenetic modulation of T cell tolerance in Multiple Sclerosis autoimmunityR01AI121405 · NIAID · OHIO STATE UNIVERSITY · PI GUERAU-DE-ARELLANO, MIREIA · 2016 to 2020
$2.2M
Detection, characterization and treatment of chronic microglial inflammation in established MS lesionsR01NS102267 · NINDS · YALE UNIVERSITY · PI PITT, DAVID · 2017 to 2021
$2.0M
3.0T Magnetic Resonance Imaging System for Preclinical, Translational and Clinical ResearchS10OD021782 · OD · WEILL MEDICAL COLL OF CORNELL UNIV · PI WANG, YI · 2016 to 2016
$2.0M
Novel knockout models to analyze CD38 functionR03AI151769 · NIAID · OHIO STATE UNIVERSITY · PI GUERAU-DE-ARELLANO, MIREIA · 2020 to 2021
$156k
NCATS NIH HHS UL1 TR001863NIAID NIH HHS R01 AI121405NIAID NIH HHS R03 AI151769NIH HHS S10 OD021782NINDS NIH HHS R01 NS090464NINDS NIH HHS R01 NS102267NINDS NIH HHS R01 NS105144
6 · The paper itself

Abstract

backgroundInflammation in chronic active lesions occurs behind a closed blood-brain barrier and cannot be detected with MRI. Activated microglia are highly enriched for iron and can be visualized with quantitative susceptibility mapping (QSM), an MRI technique used to delineate iron.

objectiveTo characterize the histopathological correlates of different QSM hyperintensity patterns in MS lesions.

methodsMS brain slabs were imaged with MRI and QSM, and processed for histology. Immunolabeled cells were quantified in the lesion rim, center, and adjacent normal-appearing white matter (NAWM). Iron

resultsQSM hyperintensity at the lesion perimeter correlated with activated iron

conclusionA high QSM signal outlining the lesion rim but not punctate signal in the center is a biomarker for chronic inflammation in white matter lesions.

Indexed as

Magnetic Resonance ImagingMicrogliaMultiple SclerosisNeuroinflammatory DiseasesWhite MatterAdultBiomarkersCells, CulturedFemaleHumansInduced Pluripotent Stem CellsIronMaleMiddle AgedBiomarkersIron

Identifiers

PMID33704933
PMCPMC8045922
OpenAlexW3134905845

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.